受强制性开放获取政策约束的文章 - Francisco Vega MD PhD了解详情
无法在其他位置公开访问的文章：12 篇
查看
MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis
YO Huh, KIC Lin, F Vega, E Schlette, CC Yin, MJ Keating, R Luthra, ...
British journal of haematology 142 (1), 36-44, 2008
强制性开放获取政策： US National Institutes of Health
查看
Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases
M Yabe, LJ Medeiros, G Tang, SA Wang, S Ahmed, Y Nieto, S Hu, ...
The American journal of surgical pathology 40 (5), 676-688, 2016
强制性开放获取政策： US National Institutes of Health
查看
Progressive leukemic non-nodal mantle cell lymphoma associated with deletions of TP53, ATM, and/or 13q14
J Chapman-Fredricks, J Sandoval-Sus, F Vega, IS Lossos
Annals of diagnostic pathology 18 (4), 214-219, 2014
强制性开放获取政策： US National Institutes of Health
查看
Unusual variants of follicular lymphoma: case-based review
JR Chapman, JP Alvarez, K White, S Sanchez, M Khanlari, K Algashaamy, ...
The American journal of surgical pathology 44 (3), 329-339, 2020
强制性开放获取政策： US National Institutes of Health
查看
Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphoma
S Gouni, P Strati, G Toruner, A Aradhya, R Landgraf, D Bilbao, F Vega, ...
Leukemia & lymphoma 63 (6), 1302-1313, 2022
强制性开放获取政策： US National Institutes of Health, Lymphoma Research Foundation, USA
查看
CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti‐CD30 CAR T‐cell therapy
ML Marques‐Piubelli, DH Kim, LJ Medeiros, W Lu, K Khan, ...
Histopathology 83 (1), 143-148, 2023
强制性开放获取政策： US National Institutes of Health
查看
Expression of BCL2 alternative proteins and association with outcome in CLL patients treated with venetoclax
ML Marques-Piubelli, EJ Schlette, JD Khoury, F Furqan, F Vega, ...
Leukemia & lymphoma 62 (5), 1129-1135, 2021
强制性开放获取政策： US National Institutes of Health
查看
Long‐term overall‐and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma
T Khashab, F Hagemeister, JE Romaguera, MA Fanale, B Pro, ...
British journal of haematology 185 (4), 670-678, 2019
强制性开放获取政策： US National Institutes of Health
查看
CD70 is a potential target biomarker in peripheral T‐cell lymphomas
ML Marques‐Piubelli, J Sagert, MT Pham, M Will, D Henderson, K Tipton, ...
Histopathology 81 (2), 272-275, 2022
强制性开放获取政策： US National Institutes of Health
查看
Precision Medicine in Diffuse Large B-Cell Lymphoma
S El Hussein, F Vega
Precision Molecular Pathology of Aggressive B-Cell Lymphomas, 179-211, 2024
强制性开放获取政策： US Department of Defense, US National Institutes of Health
查看
TCL-309: Prognostic Role of CD30 From a Retrospective Review of 295 Patients with Angioimmunoblastic T-Cell Lymphoma
S Mohamed, J Parrish, M Khan, S Premji, A Elias, L Malpica, R Nair, ...
Clinical Lymphoma Myeloma and Leukemia 21, S414, 2021
强制性开放获取政策： Department of Science & Technology, India
查看
CARDIOVASCULAR EVENTS AMONG ADULT PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA TREATED WITH STANDARD OF CARE AXICABTAGENE CILOLEUCEL AND TISAGENLECLEUCEL
R Steiner, J Banchs, E Koutroumpakis, M Becnel, C Gutierrez, P Strati, ...
Hematological Oncology 39, 2021
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：97 篇
查看
The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle, IBO Araujo, ...
Leukemia 36 (7), 1720-1748, 2022
强制性开放获取政策： US National Institutes of Health
查看
ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma
RR Singh, K Kunkalla, C Qu, E Schlette, SS Neelapu, F Samaniego, ...
Oncogene 30 (49), 4874-4886, 2011
强制性开放获取政策： US National Institutes of Health
查看
CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
V Plaks, JM Rossi, J Chou, L Wang, S Poddar, G Han, Z Wang, SQ Kuang, ...
Blood, The Journal of the American Society of Hematology 138 (12), 1081-1085, 2021
强制性开放获取政策： US National Institutes of Health
查看
Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment
S Rawal, F Chu, M Zhang, HJ Park, D Nattamai, S Kannan, R Sharma, ...
The Journal of Immunology 190 (12), 6681-6693, 2013
强制性开放获取政策： US National Institutes of Health, Doris Duke Charitable Foundation
查看
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies
A Quintas-Cardama, W Tong, T Manshouri, F Vega, PA Lennon, J Cools, ...
Leukemia 22 (6), 1117-1124, 2008
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
查看
Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB–inducing kinase while activating both canonical and alternative nuclear …
LV Pham, L Fu, AT Tamayo, C Bueso-Ramos, E Drakos, F Vega, ...
Blood, The Journal of the American Society of Hematology 117 (1), 200-210, 2011
强制性开放获取政策： US National Institutes of Health
查看
Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms
CY Ok, RR Singh, F Vega
The American journal of pathology 180 (1), 2-11, 2012
强制性开放获取政策： US National Institutes of Health
查看
Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t (14; 18 …
E Drakos, RR Singh, GZ Rassidakis, E Schlette, J Li, FX Claret, RJ Ford, ...
Leukemia 25 (5), 856-867, 2011
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定